Preserving Patient Access to Home Infusion Act
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
This bill, Preserving Patient Access to Home Infusion Act, changes federal law or congressional policy affecting health care providers and patients. The main policy domain is Healthcare, Environment, Transportation.
Who Benefits and How
health care providers and patients may benefit from new authority, funding, eligibility, regulatory clarity, or reduced risk created by the bill.
Who Bears the Burden and How
federal implementing agencies, health care providers and patients may take on implementation duties, reporting obligations, compliance costs, or oversight responsibilities.
Key Provisions
- Section HB304DB3578BA4F91B1D67D1BEF1905B0: 1. Short title This Act may be cited as the Preserving Patient Access to Home Infusion Act.
- Section HF51F4176F02E4A3E91E9E4D84F9FDA7C: 2. Preservation of patient access to home infusion therapy under Medicare program Section 1861(iii)(2) of the Social Security Act (42 U.S.C. 1395x(iii)(2)) is...
- Section HCA512E373E714894A2633B3796466348: 3. Access to home infusion for non-pump drugs and biologicals Section 1861(iii)(3) of the Social Security Act (42 U.S.C. 1395x(iii)(3)) is amended— in...
- Section HA36BF936C2D143598C4A516FC3968439: 4. Modification of payment for home infusion supplies Section 1834(a) of the Social Security Act (42 U.S.C. 1395m(a)) is amended by adding at the end the...
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
This bill, Preserving Patient Access to Home Infusion Act, changes federal law or congressional policy affecting health care providers and patients.
Key Policy Areas
Healthcare, Environment, Transportation
Primary Purpose
This bill, Preserving Patient Access to Home Infusion Act, changes federal law or congressional policy affecting health care providers and patients.
Policy Domains
Whole bill
Identified Gains
- health care providers and patients
Identified Costs
- federal implementing agencies
- health care providers and patients
Sponsors
Mark R. Warner
D-VA | Primary Sponsor
Legislative Progress
In CommitteeMr. Warner (for himself and Mr. Scott of South Carolina) …
Read twice and referred to the Committee on Finance.
Introduced in Senate
Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
- "the_secretary"
- → The Secretary identified in the operative section
Key Definitions
Terms defined in this bill
a drug or biological that—(i)is administered intravenously but not through a pump that is an item of durable medical equipment (as defined in subsection (n))
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology